Publicaciones en colaboración con investigadores/as de Uppsala University Hospital (4)

2013

  1. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: The European Forsteo Observational Study

    BMC Musculoskeletal Disorders, Vol. 14

2011

  1. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

    Osteoporosis International, Vol. 22, Núm. 10, pp. 2709-2719

2009

  1. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS)

    Calcified Tissue International, Vol. 85, Núm. 6, pp. 484-493

2008

  1. Characterization of patients in the European Forsteo Observational Study (EFOS): Postmenopausal women entering teriparatide treatment in a community setting

    Current Medical Research and Opinion, Vol. 24, Núm. 2, pp. 377-384